Participated · Seed · Nov 2021

Odonata Health is developing a proprietary, textile-based wearable garment embedded with flexible, waterproof sensors to capture maternal and fetal biometric data, including fetal heart rate and rhythm. Signal interpretation relies on proprietary AI algorithms and deep neural networks developed initially in partnership with researchers and clinicians at the Mayo Clinic. The company aims to provide clinicians with early, non-invasive indicators of fetal distress to enable timely intervention and reduce costly hospitalizations. Proceeds from its seed financing are intended to support company formation, product development, clinical validation and regulatory submission efforts. Odonata emphasizes improving access in traditionally under-served communities and is focused on maternal morbidity and mortality reduction. Its products are not yet cleared by the U.S. FDA. Marani Health offers a digital prenatal and postpartum care platform that combines the M•other consumer mobile app with a clinical care web portal to enable two-way communication and data sharing between pregnant mothers and care teams. The M•other app includes educational resources, pregnancy tracking tools, and access to the full Mayo Clinic Guide to a Healthy Pregnancy. The company plans to develop and launch its AI-driven prenatal and postpartum care platform using personalized insights to inform and reduce the cost of care. Marani raised $7.6M in Seed funding to support that development and launch. Backers include OneAlphaNorth Capital and existing investors SWL Healthcare Ventures and TFX Capital. Ann Holder is the founder and CEO, and OneAlphaNorth Managing Director Brady Lipp joined Marani’s board as part of the financing. Marani Health (formerly Odonata Health) develops an AI-powered platform for remote pregnancy care that includes a proprietary sensing device. The company was co-founded with involvement from the Mayo Clinic and aims to improve access to care and outcomes for mothers and babies. Its platform is positioned for use in both telehealth settings and clinics to provide clinicians with more pregnancy-specific data. Marani is advancing toward clinical testing and future market introduction. The company has seen heightened demand for telehealth during the COVID-19 pandemic, which it cites as driving interest in its solution. Leadership changes include the appointment of health care veteran Jodi Hubler to the board.